Ionis Pharmaceuticals, Inc.
Quick facts
| Founded | 1989 |
|---|
Phase 3 pipeline
- ION363 · Cardiovascular
ION363 is an antisense oligonucleotide that reduces production of apolipoprotein C-III (apoC-III), a protein that impairs triglyceride clearance and increases cardiovascular risk. - ION582 · Cardiovascular
ION582 is an antisense oligonucleotide that reduces production of apolipoprotein B (ApoB) to lower LDL cholesterol levels.
Phase 2 pipeline
- GHR-LRX
- ION224
- ION904
- IONIS-AGT-LRx
- IONIS DGAT2Rx
- IONIS GHR-LRx · Endocrinology
IONIS GHR-LRx is an antisense oligonucleotide that inhibits growth hormone receptor (GHR) expression to reduce growth hormone signaling. - ISIS 104838
- ISIS 14803
- ISIS 416858
- ISIS 757456
- ISIS apoC-III Rx · Cardiovascular
Antisense oligonucleotide that targets apolipoprotein C-III - ISIS CRP Rx
- ISIS-FGFR4RX · Oncology
Antisense oligonucleotide targeting fibroblast growth factor receptor 4 - ISIS-FXIRx Dose #2
- ISIS-FXIRx Dose #3
- ISIS-GCCRRx
- ISIS-GCGRRx
- ISIS-GCGRRx - Dose Level 1
- ISIS-GCGRRx - Dose Level 2
- ISIS-PTP1BRx · Metabolic/Endocrinology
ISIS-PTP1BRx is an antisense oligonucleotide that inhibits protein tyrosine phosphatase 1B (PTP1B) to improve insulin signaling and glucose metabolism.
Phase 1 pipeline
- APOC-III-L-Rx
- BIIB094
- ION251
- ION356
- ION440
- ION464
- ION537
- ION547
- ION717
- IONIS ANGPTL3-LRx
- IONIS-DMPKRx
- IONIS-ENaCRx
- IONIS FXI-LRx
- IONIS MAPTRx
- IONIS-STAT3Rx
- IONIS TMPRSS6-Lrx
- ISIS 14803, peginterferon alfa, ribavirin
- ISIS 325568
- ISIS 353512
- ISIS 388626
- ISIS 443139 10 mg
- ISIS 443139 90 mg
- ISIS EIF4E Rx
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Ionis Pharmaceuticals, Inc.
What is Ionis Pharmaceuticals, Inc.'s pipeline?
Ionis Pharmaceuticals, Inc. has 2 drugs in Phase 3, 20 in Phase 2, 23 in Phase 1. Late-stage candidates include ION363, ION582.
When was Ionis Pharmaceuticals, Inc. founded?
Ionis Pharmaceuticals, Inc. was founded in 1989.
Related
- Sector hub: All tracked pharma companies